S&P 500   2,991.48 (-0.14%)
DOW   27,014.49 (-0.04%)
QQQ   192.98 (-0.28%)
AAPL   234.58 (-0.31%)
FB   186.92 (-1.04%)
MSFT   139.84 (-1.22%)
GOOGL   1,248.53 (+0.51%)
AMZN   1,778.77 (+0.64%)
CGC   19.65 (-2.24%)
NVDA   197.60 (+0.62%)
MU   46.39 (-0.13%)
BABA   174.97 (-0.18%)
GE   8.98 (+0.90%)
TSLA   260.29 (+0.93%)
AMD   30.96 (+0.78%)
T   37.98 (+0.21%)
F   9.16 (+0.99%)
ACB   3.65 (-2.92%)
PRI   125.06 (+1.12%)
NFLX   284.16 (-0.03%)
BAC   30.55 (+2.76%)
GILD   65.63 (+0.51%)
DIS   130.12 (+0.28%)
S&P 500   2,991.48 (-0.14%)
DOW   27,014.49 (-0.04%)
QQQ   192.98 (-0.28%)
AAPL   234.58 (-0.31%)
FB   186.92 (-1.04%)
MSFT   139.84 (-1.22%)
GOOGL   1,248.53 (+0.51%)
AMZN   1,778.77 (+0.64%)
CGC   19.65 (-2.24%)
NVDA   197.60 (+0.62%)
MU   46.39 (-0.13%)
BABA   174.97 (-0.18%)
GE   8.98 (+0.90%)
TSLA   260.29 (+0.93%)
AMD   30.96 (+0.78%)
T   37.98 (+0.21%)
F   9.16 (+0.99%)
ACB   3.65 (-2.92%)
PRI   125.06 (+1.12%)
NFLX   284.16 (-0.03%)
BAC   30.55 (+2.76%)
GILD   65.63 (+0.51%)
DIS   130.12 (+0.28%)
Log in

Cardlytics Stock Price, News & Analysis (NASDAQ:CDLX)

$37.63
-0.62 (-1.62 %)
(As of 10/16/2019 09:58 AM ET)
Today's Range
$37.63
Now: $37.63
$38.16
50-Day Range
$32.81
MA: $35.46
$38.70
52-Week Range
$9.80
Now: $37.63
$39.62
Volume1,706 shs
Average Volume403,083 shs
Market Capitalization$859.15 million
P/E RatioN/A
Dividend YieldN/A
Beta1.49
Cardlytics, Inc operates a purchase intelligence platform in the United States and the United Kingdom. It operates in two segments, Cardlytics Direct and Other Platform Solutions. The company's platform is the Cardlytics Direct solution, a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. Read More…

Industry, Sector and Symbol

Industry Computer programming, data processing, & other computer related
Sub-IndustryN/A
SectorBusiness Services
Current SymbolNASDAQ:CDLX
CUSIPN/A
Phone888-798-5802

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$150.68 million
Book Value$2.56 per share

Profitability

Net Income$-53,040,000.00

Miscellaneous

EmployeesN/A
Market Cap$859.15 million
Next Earnings Date11/12/2019 (Estimated)
OptionableNot Optionable

Receive CDLX News and Ratings via Email

Sign-up to receive the latest news and ratings for CDLX and its competitors with MarketBeat's FREE daily newsletter.


Cardlytics (NASDAQ:CDLX) Frequently Asked Questions

What is Cardlytics' stock symbol?

Cardlytics trades on the NASDAQ under the ticker symbol "CDLX."

How were Cardlytics' earnings last quarter?

Cardlytics Inc (NASDAQ:CDLX) issued its quarterly earnings data on Thursday, August, 8th. The company reported ($0.12) earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($0.35) by $0.23. The business had revenue of $48.73 million for the quarter, compared to analysts' expectations of $43.77 million. Cardlytics had a negative return on equity of 66.01% and a negative net margin of 19.60%. The company's revenue for the quarter was up 37.0% on a year-over-year basis. During the same period in the prior year, the firm earned ($0.21) EPS. View Cardlytics' Earnings History.

When is Cardlytics' next earnings date?

Cardlytics is scheduled to release their next quarterly earnings announcement on Tuesday, November 12th 2019. View Earnings Estimates for Cardlytics.

What guidance has Cardlytics issued on next quarter's earnings?

Cardlytics issued an update on its third quarter 2019 earnings guidance on Thursday, August, 8th. The company provided EPS guidance of for the period. The company issued revenue guidance of $46-50 million, compared to the consensus revenue estimate of $48.15 million.

What price target have analysts set for CDLX?

7 brokers have issued 12-month target prices for Cardlytics' shares. Their forecasts range from $26.00 to $43.00. On average, they expect Cardlytics' share price to reach $33.67 in the next year. This suggests that the stock has a possible downside of 10.5%. View Analyst Price Targets for Cardlytics.

What is the consensus analysts' recommendation for Cardlytics?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardlytics in the last year. There are currently 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Cardlytics.

What are Wall Street analysts saying about Cardlytics stock?

Here are some recent quotes from research analysts about Cardlytics stock:
  • 1. According to Zacks Investment Research, "Cardlytics, Inc. is engaged in developing a purchase intelligence platform. The purchase data includes debit, credit and bill pay data from online and in-store transactions. It helps the marketers identify, reach and influence likely buyers at scale, and measure the impact of marketing spends. The Company also operates an advertising channel, Cardlytics Direct. Cardlytics Direct delivers tailored marketing for marketers and financial institutions. Cardlytics, Inc. is based in ATLANTA, United States. " (10/15/2019)
  • 2. SunTrust Banks, Inc. analysts commented, "We hosted Cardlytics’ CEO and Co-Founder, Scott Grimes, and COO and Co- Founder, Lynne Laube, at our 6th annual internet and digital media conference for a fireside chat." (5/21/2019)

Has Cardlytics been receiving favorable news coverage?

Media coverage about CDLX stock has trended very negative recently, according to InfoTrie Sentiment. InfoTrie identifies negative and positive news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Cardlytics earned a daily sentiment score of -3.3 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 8.0 out of 10, indicating that recent news coverage is very likely to have an effect on the stock's share price in the near future. View News Stories for Cardlytics.

Are investors shorting Cardlytics?

Cardlytics saw a increase in short interest in the month of September. As of September 30th, there was short interest totalling 3,410,000 shares, an increase of 11.4% from the August 30th total of 3,060,000 shares. Based on an average daily volume of 453,800 shares, the short-interest ratio is presently 7.5 days. Approximately 16.8% of the shares of the stock are sold short. View Cardlytics' Current Options Chain.

Who are some of Cardlytics' key competitors?

What other stocks do shareholders of Cardlytics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardlytics investors own include Caterpillar (CAT), Okta (OKTA), Alibaba Group (BABA), Twilio (TWLO), Shopify (SHOP), Store Capital (STOR), Coupa Software (COUP), Cyberark Software (CYBR), Nutanix (NTNX) and Trade Desk (TTD).

Who are Cardlytics' key executives?

Cardlytics' management team includes the folowing people:
  • Mr. Scott D. Grimes, Co-Founder, CEO & Director (Age 56)
  • Ms. Lynne Marie Laube, Co-Founder, COO & Director (Age 49)
  • Mr. David Evans, CFO & Head of Corp. Devel.
  • Mr. Sathish Gaddipati, Chief Technology Officer (Age 52)
  • Mr. Kirk L. Somers, Chief Legal & People Officer (Age 54)

When did Cardlytics IPO?

(CDLX) raised $76 million in an initial public offering on Friday, February 9th 2018. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. BofA Merrill Lynch and J.P. Morgan acted as the underwriters for the IPO and Wells Fargo Securities, SunTrust Robinson Humphrey, Raymond James and KeyBanc Capital Markets were co-managers.

How do I buy shares of Cardlytics?

Shares of CDLX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Cardlytics' stock price today?

One share of CDLX stock can currently be purchased for approximately $37.63.

How big of a company is Cardlytics?

Cardlytics has a market capitalization of $859.15 million and generates $150.68 million in revenue each year. The company earns $-53,040,000.00 in net income (profit) each year or ($2.14) on an earnings per share basis. View Additional Information About Cardlytics.

What is Cardlytics' official website?

The official website for Cardlytics is http://www.cardlytics.com/.

How can I contact Cardlytics?

Cardlytics' mailing address is 675 PONCE DE LEON AVENUE NE SUITE 6000, ATLANTA GA, 30308. The company can be reached via phone at 888-798-5802 or via email at [email protected]


MarketBeat Community Rating for Cardlytics (NASDAQ CDLX)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  141 (Thanks for Voting!)
Underperform Votes:  189 (Thanks for Voting!)
Total Votes:  330
MarketBeat's community ratings are surveys of what our community members think about Cardlytics and other stocks. Vote "Outperform" if you believe CDLX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CDLX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/16/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel